Title
|
Company Name
|
Platform /
Modality
|
Target
|
Investor/Partner
Relations
|
| A New Class of Pan-HER Antagonists to Treat Cancer |
Molecular LogiX |
Biologic |
HER family of receptor tyrosine kinases |
VC, Strategic Partner |
| A Novel Treatment for Chronic Pain |
Advanced Targeting Systems |
Other |
Substance P receptor-positive neurons that carry the chronic pain signal to the brain. |
Licensing, Strategic Partner |
| Antiangiogenic Method of Treating Early Stage Breast Cancer |
Electron Optics Development Co., LLC |
Other (Method to use antiangiogenic therapy in early stage cancer) |
Prevent angiogenesis of dormant micrometastases |
VC, Licensing, Strategic Partner |
| Antibody-based Therapies for Treating Substance Abuse |
InterveXion Therapeutics, LLC |
Antibody |
drugs of abuse |
VC, Licensing, Manufacturing, Strategic Partner |
| Bisphosphonate Conjugates for Treatment of Cancer-induced Bone Diseases |
MBC Pharma, Inc |
Small Molecules |
|
VC, Licensing, Strategic Partner |
| CDD-0102 for the Treatment of Alzheimer's Disease |
Cognitive Pharmaceuticals, Ltd. |
Small Molecules |
M1 muscarinic receptors, which play key roles in memory and cognition, as well as initiate beneficial pathways in the brain. |
VC, Licensing, Strategic Partner |
| Colonic Cells:Non-Invasive Isolation Technology |
NonInvasive Technologies LLC |
Biologic |
Adult progenitor cells in immunotherapy of cancer |
Licensing, Strategic Partner |
| Development of a Novel Anti-Diabetes Agent |
Preventive Nutrient Co., Inc |
Other (Anti-disbetes sgent) |
Treatment of Type 2 Diabetes |
Strategic Partner |
| Heart Failure Diagnostic and Clinical Trial Enrollment Tool |
Gwathmey, Inc. |
Small Molecules |
Selection of responders and non-responders for clinical trials |
VC, Licensing, Strategic Partner |
| Heat Shock Protein |
Sequella, Inc. |
Other |
|
Licensing |
| Human Mini-Tumor Bioassay Platform to Identify Drug Candidates & Patient Profiling |
Vivo Biosciences Inc |
Biologic |
Preclinical Drug discovery, Patient Chemo-prediction |
VC, Licensing, Manufacturing, Strategic Partner |
| Implantable Left Ventricular Assist Pump for Heart Failure Patients |
MiTiHeart Corporation |
Other |
|
VC, Licensing, Strategic Partner |
| Laser Activated Tissue Adhesive and Sealant |
Conversion Energy Enterprises, Inc. |
Point of Care |
Hernia Repair |
Strategic Partner |
| LifeZig Personalized Reminiscence Video System |
Photozig, Inc. |
Multimedia/IT |
|
VC, Licensing, Strategic Partner |
| Long-acting Native GLP-1 Frmulation for the Treatment of Diabetes |
PharmaIN, Ltd. |
Biologic |
GLP-1 receptor (glucagon-like peptide 1 receptor) |
VC, Licensing, Strategic Partner |
| Metagenomic Drug Discovery |
eMetagen Corporation |
Small Molecules |
Multiple drug-resistant pathogens |
VC, Licensing, Strategic Partner |
| Novel Neurorestorative Therapy for Multiple Sclerosis |
Cognosci, Inc. |
Small Molecules |
Rebuilding of myelin and neuroprotective activity and anti-inflammatory |
VC, Licensing, Strategic Partner, Other |
| Novel Restorative Therapy for Traumatic Brain Injury |
Cognosci, Inc. |
Small Molecules |
Short and Long Term Improvement of Motor and Behavioral Functions |
VC, Licensing, Strategic Partner, Other |
| Novel Technology for cost-effective production of improved antibodies |
ApoLife, Inc. |
Antibody |
CLL and breast cancer |
VC, Licensing, Manufacturing, Strategic Partner |
| SERF Ablation [TM] for Cancer Therapy and Cardiac Arrhythmias |
Thermedical |
Point of Care |
|
VC |
| SQ609 |
Sequella, Inc. |
Small Molecules |
|
VC, Licensing, Manufacturing, Strategic Partner, Other |
| Ultra Low Profile Angioplasty Balloon Catheter |
Zylon Corporation |
Point of Care |
|
VC, Licensing, Manufacturing, Strategic Partner |
| Wound closure device |
Surgical Eneregetics Inc. |
Other (Wound closure) |
Reconstructive and Orthopedic Surgery |
VC, Licensing |
represents column sort